A blood test can predict the risk of dementia in women up to 25 years before symptoms appear, researchers say.Experts in the US found that higher levels of a protein called p-tau217 – which is linked ...

A simple blood test identified women at higher risk for dementia up to 25 years before symptoms appeared. Higher levels of ...

Researchers say elevated p-tau217 levels in older women were strongly linked to future dementia, raising hopes for earlier ...

A long-term study of 2,766 women in the Women’s Health Initiative Memory Study found that higher baseline plasma p-tau217 levels were associated with a greater risk of developing mild cognitive ...

Researchers have identified a blood marker that could help detect dementia risk in women decades before symptoms begin, potentially transforming early prevention strategies.

The blood biomarker p-tau217 has "shown the most promise in detecting Alzheimer's in the brain," researchers of a new study say.

Experts in the US found that higher levels of a protein called p-tau217 were an accurate predictor of people developing cognitive problems and dementia.

Scientists found that a blood protein called p tau217 may reveal dementia risk up to 25 years before symptoms appear.

Rising diagnoses of young onset dementia highlight the need for early recognition and timely evaluation of a condition that disrupts patients’ careers, families, and financial stability.

Experts say the discovery might mean women could be given help long before memory problems affect their daily life ...

Women with higher levels of p-tau217, a blood protein, were twice as likely to eventually develop dementia or mild cognitive impairment.